154 results
8-K
EX-99.1
ACORQ
Acorda Therapeutics Inc
11 Jan 24
Termination of a Material Definitive Agreement
8:33am
for the improvement of walking in adults with multiple sclerosis (MS) with walking disability. Acorda markets the medication as AMPYRA® (dalfampridine … in adult patients with multiple sclerosis (MS) with walking disability (EDSS 4-7). In clinical trials the highest incidence of adverse reactions
S-8
EX-4.7
r8gbf0vdpath an8h
16 Aug 22
Registration of securities for employees
4:31pm
PRE 14A
94unoc9
3 Apr 20
Preliminary proxy
5:25pm
8-K
EX-4.1
tv4ulcv990fhacfhpd
26 Dec 19
Entry into a Material Definitive Agreement
8:21am